Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Inducer Micrornas in the Glioma Development: A Concise Review of Mechanisms and Insights Into Targeted Therapy Publisher Pubmed



M Pourrahimi MAHYA ; M Hesari MARJAN ; H Houshmandpour HANNANEH ; O Mirzaee OMID ; H Fouladseresht HAMED ; E Torki ENSIYE ; H Kouchaki HOSEIN ; R Tabrizi REZA ; A Ghasemian ABDOLMAJID ; S Barbaresi SILVIA
Authors

Source: Journal of the Egyptian National Cancer Institute Published:2025


Abstract

Gliomas represent predominant and fatal central nervous system (CNS) cancers lacking a gold standard of treatment, which need accurate prognosis, diagnosis, and intervention. Glioma accurate therapy using common traditional approaches such as surgical treatment, radiotherapy, and chemotherapy results insufficient mainly due to side effects, recurrence, and resistance. Scientific and medical challenges can be decreased considering novel therapeutic targets. The multiple and diverse role of microRNAs (miRNAs) in cellular processes has been demonstrated. The appreciation of miRNAs regulatory roles in cancer cell proliferation or growth inhibition opens new perspectives in the development of novel strategies targeting cancers. Six inducers (miRNAs) including miR-363-3P, miR720, miR-484, miR-890, miR-496, and miR-939-5p can develop into glioma cells with the potential of therapeutic targets. Therefore, the tracking of glioma stage and response to anticancer therapy is associated with various miRNAs. The objective of this review is to provide a comprehensive assessment of the role of miRNAs in glioma cancer development. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
10. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)